HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

deferasirox

for the treatment of chronic iron overload from blood transfusions
Also Known As:
4-(3,5-bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid; Exjade; ICL 670; ICL 670A; ICL-670; ICL-670A; ICL670; ICL670A
Networked: 391 relevant articles (72 outcomes, 94 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Habr, Dany: 25 articles (09/2015 - 06/2009)
2. Porter, John B: 22 articles (09/2015 - 10/2006)
3. Cappellini, Maria Domenica: 21 articles (03/2015 - 05/2006)
4. Piga, Antonio: 17 articles (09/2015 - 06/2003)
5. Galanello, Renzo: 16 articles (11/2013 - 06/2003)
6. Kattamis, Antonis: 15 articles (06/2015 - 05/2006)
7. Forni, Gian Luca: 13 articles (04/2015 - 07/2006)
8. Porter, John: 13 articles (02/2013 - 05/2006)
9. Taher, Ali: 12 articles (06/2014 - 01/2009)
10. Vichinsky, Elliott: 12 articles (12/2013 - 02/2007)

Related Diseases

1. Iron Overload
2. beta-Thalassemia (Cooley's Anemia)
3. Thalassemia
4. Myelodysplastic Syndromes (Myelodysplastic Syndrome)
5. Anemia

Related Drugs and Biologics

1. Iron
2. deferasirox
3. Deferoxamine (Desferal)
4. deferiprone (CP20)
5. liposomal amphotericin B
6. Ferritins (Ferritin)
7. Chelating Agents
8. caspofungin (Cancidas)
9. Hemoglobins (Hemoglobin)
10. Iron Chelating Agents

Related Therapies and Procedures

1. Chelation Therapy (Therapy, Chelation)
2. Drug Therapy (Chemotherapy)
3. Blood Transfusion (Blood Transfusions)
4. Transplantation (Transplant Recipients)
5. Stents